Changes of diet and lack of exercise in modern lifestyles have brought about an increase in the incidence of obesity and metabolic syndrome, which are attracting the attention of researchers as major risk factors for cardiovascular events such as heart attacks and strokes. While it is thought that metabolic syndrome is accompanied by a chronic inflammatory response in obese adipose tissue that brings about these symptoms, the mechanisms by which this comes about are not well understood.
In 2009, researchers at the University of Tokyo’s Department of Cardiovascular Medicine including Associate Professor Satoshi Nishimura (Translational Systems Biology and Medicine Initiative), Lecturer Ichiro Manabe, Emeritus Professor Ryozo Nagai and their colleagues found that CD8+ T-cells (also known as killer T-cells) brought about adipose inflammation.
In this latest research, the group reports for the first time that regulatory B cells in mouse adipose tissue have anti-inflammatory properties. Further, they also report that these B cells are reduced in obesity both in mice and humans. As a result, it is possible that inflammation is brought about by an imbalance in the cells promoting and suppressing inflammation. The group also found that Interleukin-10 produced by B cells is vital for B cell function. Based on these findings, it is expected that regulatory B cells will prove a novel therapeutic target for metabolic syndrome.
Source: University of Tokyo